Medicinal Herbs: From Traditional Use to Modern Evidence

What are medicinal herbs?

A medicinal herb is a plant or plant part used for a health-related purpose in a traditional practice, a modern preparation or scientific research. The broader term “botanical” can include herbs as well as bark, roots, flowers, seeds and other plant material. Ginger rhizome, peppermint leaf, turmeric rhizome and chamomile flower illustrate why the part matters: two products sharing a common plant name may not contain the same material.

The word “medicinal” describes use or research interest; it is not an FDA approval and does not mean that every traditional claim has been established. In the United States, an herbal product swallowed as a capsule, gummy, powder or liquid may be marketed as a dietary supplement if it meets the legal definition and labeling requirements. Dietary supplements are regulated differently from drugs and generally are not approved by FDA for safety and effectiveness before reaching the market.

Herbs should also be distinguished from functional mushrooms. Mushrooms are fungi, not plants. Both may appear in wellness traditions and supplements, but their taxonomy, constituents, preparation and evidence bases differ. Cannabis is a botanical; CBD is one constituent that may be extracted from hemp. These distinctions help readers avoid treating every natural product as one category.

The modern question is therefore more specific than “Do medicinal herbs work?” A useful evaluation asks: Which species and part? Which preparation and amount? For which person and outcome? Compared with what? What adverse effects and interactions were measured? Without those details, a broad benefit claim is not testable.

A cross-cultural history of medicinal plants

Human communities developed plant knowledge through observation, experience, trade, agriculture, ceremony and systems of healing. Written records survive from several ancient societies, but written survival should not be confused with the beginning of knowledge. Indigenous and oral traditions often transmitted sophisticated information without the kinds of documents preserved in libraries.

Mesopotamia and Egypt

Clay tablets from ancient Mesopotamia and Egyptian medical papyri record plant materials alongside minerals, animal products and ritual practices. The Ebers Papyrus, conventionally dated to the second millennium BCE, is frequently cited because it preserves hundreds of formulations. It should be read as evidence of historical practice, not as a modern clinical manual. Translating ancient plant names and preparations into current species and doses can be uncertain.

South Asian traditions

Ayurvedic traditions developed extensive systems that connect diet, behavior, plant preparations and individualized patterns. Texts associated with the Charaka and Sushruta traditions influenced medical thought across centuries. Modern research may study individual plants used in Ayurveda, but removing one ingredient from its historical context and selling it with a universal claim can distort both the tradition and the science.

Chinese materia medica

Chinese medical traditions recorded materia medica, formulations and methods of preparation over many dynasties. The text known as the Shennong Bencao Jing became an influential early compilation. Contemporary traditional Chinese medicine remains a living practice, not merely an ancient artifact. Evidence for a particular formula or herb still needs to specify composition, diagnostic context, controls and safety.

Greek, Roman and later Mediterranean records

Greek and Roman authors described plant identification and uses, while Dioscorides’ De materia medica influenced medicine and pharmacy for many centuries. Knowledge moved through translation, trade and scholarship across Greek, Roman, Byzantine, Islamic, Jewish and European communities. Figures such as Ibn Sina and Maimonides worked within broader intellectual networks; presenting the history as a single straight line toward modern Western medicine erases that exchange.

Indigenous knowledge and colonial extraction

Indigenous peoples across the Americas, Africa, Oceania and elsewhere maintained place-specific botanical knowledge. Some plant-derived medicines and research leads emerged from that knowledge, yet colonial collection sometimes separated plants from their cultural ownership and failed to share credit or benefit. A responsible history names knowledge systems carefully, avoids treating them as folklore to be mined, and recognizes conservation and access concerns.

What traditional use can, and cannot, tell us

Longstanding use can suggest that a plant was culturally important, that communities developed preparation methods, or that an effect was repeatedly perceived. It can help researchers select questions and identify possible safety signals. It may also preserve values that a narrow biomedical trial does not measure, including ritual, identity, community care and relationship to place.

But duration of use alone cannot determine effectiveness. Historical records may use a common name for several species, describe a preparation unlike a modern extract, or combine multiple ingredients. People who did not benefit may be less visible in the record. Adverse effects may not have been systematically captured. A tradition may also include symbolic or spiritual purposes that should not be rewritten as biochemical claims.

The opposite error is to dismiss traditional knowledge simply because it was not generated by a randomized trial. The productive approach is to identify what kind of knowledge a source contains and avoid asking it to prove a different kind of claim. Historical documentation answers “what was used, where, by whom and how?” Pharmacology asks what constituents and mechanisms may be involved. Clinical research asks whether a defined intervention produces a meaningful outcome in a defined population.

This distinction also protects cultural accuracy. “Used traditionally for” is not a decorative phrase to place above a product benefit. It should be traceable to a specific tradition and preparation, and it should not imply endorsement by the people whose knowledge is referenced.

The evidence ladder for medicinal herbs

Quality matters at every rung. A botanical study should authenticate the species and plant part. Researchers need to characterize extracts so another team can reproduce the work. Trials should predefine outcomes, report adverse events and disclose funding. A positive result from one small trial should not be expanded into a guarantee.

Relevance to a product is another gate. A trial of a standardized root extract does not automatically support a tea made from leaves. A concentrated essential oil may have a very different exposure from a culinary herb. If a supplement contains several ingredients, evidence for one ingredient cannot establish the combination’s benefit or safety.

Four examples that resist one-size-fits-all claims

Ginger

Ginger appears in food and in concentrated supplements. Human research has examined specific preparations for nausea and other outcomes, but results and appropriate use vary. Culinary familiarity does not answer whether a concentrated supplement is suitable during pregnancy, with anticoagulants or before surgery. The exact product and clinical context still matter.

St. John’s wort

St. John’s wort is a powerful example of why “natural” is not a synonym for gentle. It can affect drug-metabolizing pathways and reduce the effectiveness of important medicines, including some birth-control, transplant, HIV, cardiovascular and other therapies. It may also create serious serotonergic interactions with certain antidepressants. A broad “stress support” label would not communicate those risks.

Turmeric and curcumin

Turmeric is a food spice, while many supplements use concentrated curcumin extracts and may add ingredients intended to change absorption. Studies use different formulations, and bioavailability strategies can change exposure and interaction questions. Laboratory anti-inflammatory activity does not prove that every turmeric gummy treats pain or inflammatory disease.

Peppermint

Peppermint tea, enteric-coated peppermint oil and topical essential oil are different preparations. NIH consumer guidance notes that concentrated oils can carry risks not suggested by ordinary tea use. This is why a list of “benefits of peppermint” without form and amount is incomplete.

These examples are not a menu of treatments. They demonstrate the method: identify the preparation, then examine human evidence, adverse effects and interactions for the intended use.

Tea, tincture, powder and extract are not interchangeable

A tea extracts water-soluble constituents at a strength affected by plant amount, water temperature and steeping time. A tincture commonly uses alcohol or another solvent and may concentrate a different chemical profile. A dried powder contains plant material in a less selective form. A standardized extract may target a constituent or ratio, though the word “standardized” alone does not guarantee overall quality.

Essential oils are highly concentrated volatile fractions and can be unsafe when swallowed or applied improperly. A safe culinary amount does not establish a safe essential-oil amount. Gummies add formulation constraints: limited space, sweeteners, flavors and sometimes multiple actives. The attractive format can make a supplement feel like food even when its ingredients have meaningful biological effects.

Labels may express amounts as raw-herb equivalent, extract weight or a proprietary blend total. Those are not the same. If individual active amounts are hidden within one blend, a reader cannot compare the serving with research or reliably evaluate changes between products.

Herbal safety, medication interactions and higher-risk situations

FDA and NIH guidance both emphasize that supplements can have strong effects and may interact with medicines. An herb can change absorption, metabolism or excretion, raising or lowering drug exposure. Interaction data are incomplete for many combinations, so absence from an online checker is not proof of safety.

People using medicines with a narrow therapeutic index need particular caution because relatively small changes in drug levels can matter. Anticoagulants, immunosuppressants, seizure medicines, antidepressants, blood-pressure drugs and diabetes medicines are among the categories that deserve professional review. Bring the exact product, serving and full medication list to a pharmacist or clinician.

Pregnancy and breastfeeding require additional caution because safety data are often limited and fetal or infant exposure may differ. Children are not small adults, and a gummy marketed for general wellness is not automatically appropriate for them. Liver or kidney disease can change metabolism and clearance. Allergy is possible, and people preparing for surgery should disclose every supplement because bleeding, sedation, blood pressure or anesthesia interactions may be relevant.

Stop use and seek advice after a suspected adverse reaction. Severe breathing difficulty, facial swelling, fainting, chest symptoms, confusion or another acute emergency needs urgent care. In the United States, adverse events can also be reported through FDA MedWatch.

A practical botanical supplement checklist

1. Botanical identity: Look for common and scientific names so similarly named species are not confused.
2. Plant part: Root, leaf, flower, bark, seed and oil can have different constituents.
3. Preparation: Note whether it is powder, tincture, tea, essential oil or a defined extract and solvent ratio.
4. Amount and serving: Confirm the quantity per unit and how many units form one serving.
5. Other ingredients: Review added botanicals, cannabinoids, stimulants, allergens, sweeteners and absorption enhancers.
6. Traceability: Find a manufacturer, lot number and contact route. A QR code should open a record that matches the lot.
7. Testing scope: Identity, potency and contaminants answer different questions. Look for relevant heavy-metal, pesticide, solvent and microbial panels.
8. Claim discipline: Avoid products promising to cure disease, replace prescriptions or work for everyone.

FDA good manufacturing practice requirements are designed to support identity, purity, strength and composition. Independent quality seals may add manufacturing assurance, but NIH notes that such seals do not guarantee safety or effectiveness. Quality control and clinical evidence are related but separate questions.

How this history connects to Mood Wellness

Mood Wellness publishes this article and sells cannabinoid and functional-mushroom supplements. This page is not a product-benefit list. Its purpose is to give readers a repeatable way to evaluate natural-product claims. Mood’s functional mushrooms are fungi rather than medicinal herbs, while hemp is botanical; both still require precise ingredient descriptions, evidence boundaries and batch transparency.

Readers can review Mood’s ingredients, process and standards, and current lab reports. Those pages can help verify what a Mood product contains. They do not convert a supplement into an FDA-approved treatment or predict an individual outcome.

If you are considering a Mood formula, use the same framework applied to an herb: identify every active, read the labeled serving, check cannabinoid and THC content, match the lot report, and discuss medication or condition-specific questions with a professional. The most honest bridge from history to commerce is better evidence literacy, not a promise that ancient equals effective.

Sources and editorial review